Sarepta Therapeutics (SRPT) PT Lowered to $35 at Oppenheimer
Tweet
Share
E-mailGet Alerts SRPT Hot Sheet
Price: $18.67 +1.52%
Rating Summary:
19 Buy, 18 Hold, 6 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 5 | New: 19
Rating Summary:
19 Buy, 18 Hold, 6 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 5 | New: 19
Join SI Premium – FREE
Oppenheimer analyst Andreas Argyrides lowered the price target on Sarepta Therapeutics (NASDAQ: SRPT) to $35.00 (from $37.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Jefferies on Sarepta Therapeutics (SRPT): 'The risk/reward seems favorable'
- Slate Grocery REIT (SGR-U:CN) (SRRTF) PT Lowered to $8.25 at CIBC
- Infosys Ltd. (INFO:IN) (INFY) PT Lowered to INR1,430 at UBS
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
